| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/AJT.13725 |
| P698 | PubMed publication ID | 26790369 |
| P50 | author | Eva Guinan | Q64788601 |
| P2093 | author name string | H Yuan | |
| G A Cole | |||
| J Markmann | |||
| L A Turka | |||
| L L Brennan | |||
| J Oppatt | |||
| K J Janec | |||
| R H Kelner | |||
| W H Wylie | |||
| P2860 | cites work | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics | Q34144161 |
| Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation | Q34162461 | ||
| Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue | Q34922714 | ||
| Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. | Q34969823 | ||
| Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation | Q35575711 | ||
| Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses | Q35578669 | ||
| Effect of uremia on structure and function of immune system | Q35635884 | ||
| Engineering lymphocyte subsets: tools, trials and tribulations | Q36140986 | ||
| Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies | Q36868702 | ||
| Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation. | Q37065658 | ||
| Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy | Q37294572 | ||
| Prolongation of renal allograft survival by anergic cells: advantages and limitations | Q37768807 | ||
| Regulatory T cell therapy for the induction of clinical organ transplantation tolerance | Q37932810 | ||
| CD4(+)Foxp3(+) regulatory T cell therapy in transplantation | Q37968576 | ||
| T regulatory cell therapy in transplantation: stability, localization and functional specialization | Q38025842 | ||
| Immune cell dysfunction and inflammation in end-stage renal disease | Q38090908 | ||
| Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials | Q39431833 | ||
| Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation | Q39702510 | ||
| Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates | Q42846864 | ||
| Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation | Q43655192 | ||
| Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. | Q45299244 | ||
| DNA methylation controls Foxp3 gene expression | Q46391168 | ||
| Costimulation blockade with belatacept in renal transplantation | Q46569880 | ||
| Uremia-associated immunological aging is stably imprinted in the T-cell system and not reversed by kidney transplantation. | Q50789254 | ||
| DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. | Q52924279 | ||
| Transplantation of anergic histoincompatible bone marrow allografts | Q56906962 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2187-2195 | |
| P577 | publication date | 2016-03-11 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Ex Vivo Costimulatory Blockade to Generate Regulatory T Cells From Patients Awaiting Kidney Transplantation | |
| P478 | volume | 16 |
| Q39279238 | Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells |
| Q89402892 | DEPTOR modulates activation responses in CD4+ T cells and enhances immunoregulation following transplantation |
| Q64982406 | Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. |
| Q47157103 | Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio. |
| Q64236635 | Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity |
| Q38662974 | Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. |
| Q50319201 | Regulatory T cells in renal disease. |
| Q95645109 | Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials |
| Q40989146 | Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways |
Search more.